Acutaas Chemicals Limited (BOM:543349)

Market Cap	165.18B +111.3%
Revenue (ttm)	12.15B +31.6%
Net Income	2.87B +136.4%
EPS	34.76 +159.1%
Shares Out	n/a
PE Ratio	57.56
Forward PE	44.88
Dividend	1.50 (0.07%)
Ex-Dividend Date	Sep 18, 2025

Volume	34,899
Average Volume	33,639
Open	2,087.00
Previous Close	2,095.00
Day's Range	2,010.35 - 2,102.85
52-Week Range	930.03 - 2,120.00
Beta	n/a
RSI	62.50
Earnings Date	Jan 28, 2026

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 879
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543349

Financial Performance

In fiscal year 2025, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.